1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3) Antibody

Este producto es parte de AGPAT - 1-acyl-sn-glycerol-3-phosphate acyltransferase
Product Graph
52€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx014067
tested applications
ELISA, WB

Description

Rabbit polyclonal antibody against AGPAT3 protein. Immunogen region is Internal.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1/500 - 1/3000, ELISA: 1/40000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Size 1
10 µg
Size 2
100 µg
Size 3
200 µg
Size 4
300 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB
Buffer
PBS (without Mg<sup>2+</sup> and Ca<sup>2+</sup>), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9NRZ7
Alias
1-AGPAT 3,LPAAT-GAMMA1
Background
Antibody anti-AGPAT3
Status
RUO
Note
Concentration: 1 mg/ml - 

Descripción

AGPAT3 is another member of the AGPAT family involved in the acylation of lysophosphatidic acid (LPA) to form phosphatidic acid (PA). Unlike AGPAT1 and AGPAT2, AGPAT3 has broader substrate specificity and is expressed in multiple tissues, including the liver, brain, and kidneys. It participates in the synthesis of various phospholipids, such as phosphatidylcholine and phosphatidylethanolamine, which are essential for membrane biogenesis and cell signaling. AGPAT3 also plays a role in lipid remodeling and vesicle trafficking. Dysregulation of AGPAT3 has been associated with metabolic disorders, and emerging research suggests its potential involvement in neurological diseases and cancer due to its impact on membrane composition and signaling pathways.

Related Products

FNab00216

anti- AGPAT3 antibody

Converts lysophosphatidic acid(LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. Acts on LPA containing saturated or unsaturated fatty acids C16:0-C20:4 at the sn-1 position using C18:1, C20:4 or C18:2-CoA as the acyl donor. Also acts on lysophosphatidylcholine, lysophosphatidylinositol and lysophosphatidylserine using C18:1 or C20:4-CoA(PubMed:21173190). Has a preference for arachidonoyl-CoA as a donor. Has also a modest lysophosphatidylinositol acyltransferase(LPIAT) activity, converts lysophosphatidylinositol(LPI) into phosphatidylinositol(By similarity).

Ver Producto
abx014067

1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3) Antibody

Rabbit polyclonal antibody against AGPAT3 protein. Immunogen region is Internal.

Ver Producto
abx036383

1-Acylglycerol-3-Phosphate O-Acyltransferase 3 (AGPAT3) Antibody

Rabbit Polyclonal against the AGPAT3 protein.

Ver Producto